Arteaus Therapeutics Headquarters
Looking for information about Arteaus Therapeutics Headquarters? The links below have collected all the necessary data.
Arteaus Therapeutics - Atlas Venture
- https://atlasventure.com/company/arteaus-therapeutics
- Nov 25, 2014 · Arteaus Therapeutics. In December 2013 Eli Lilly and Company (NYSE:LLY) acquired all development rights for Arteaus Therapeutics’ calcitonin gene-related peptide (CGRP) antibody upon the completion of a Phase 2a clinical trial for the prevention of frequent, recurrent migraine headaches. Headquarters. Cambridge, MA. Website. www.arteaus.com .Headquarters: Cambridge, MA
Arteaus Therapeutics - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/arteaus-therapeutics
- Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date 2011. Founders Jean-Francois Formela, Scott Chappell. Operating Status Active. Last Funding Type Venture - Series Unknown. Company Type For Profit. Contact Email [email protected]. Phone Number 617.588.2628. Arteaus Therapeutics, LLC, a Cambridge, Massachusetts-based ...Founded: 2011
Arteaus Therapeutics’s Competitors, Revenue, Number of ...
- https://www.owler.com/company/arteaus
- Arteaus Therapeutics is developing novel therapies for migraine prevention. Arteaus Therapeutics was founded in 01/2011. Arteaus Therapeutics' headquarters is located in Cambridge, Massachusetts, USA 02141. It has raised 30.0M in 2 rounds. The latest ...
Arteaus Therapeutics - thepharmaletter.com
- https://www.thepharmaletter.com/company/arteaus-therapeutics
- Arteaus Therapeutics is a US biotech company developing novel therapies for migraine prevention. Arteaus was formed in 2011 with an $18 million investment from Atlas Venture and OrbiMed, upon acquiring the rights to develop Eli Lilly's calcitonin gene-related peptide (CGRP) antibody. In June 2012, Arteaus began clinical trials of LY2951742, an ...
Arteaus Therapeutics, LLC in Cambridge, MA Company Info ...
- https://www.bizapedia.com/ma/arteaus-therapeutics-llc.html
- Arteaus Therapeutics, LLC is a Massachusetts Foreign Limited-Liability Company (Llc) filed On July 15, 2011. The company's File Number is listed as 452547171. The Registered Agent on file for this company is David Grayzel and is located at 25 First Street Suite 303, Cambridge, MA 02141.Founded: Jul 15, 2011
Asset-Centric: Arteaus Therapeutics - Atlas Venture
- https://atlasventure.com/case-study/arteaus-therapeutics
- Pioneering the “Built-to-Buy” Structured Exit. Backdrop: As large pharma companies compress their R&D budgets, high-quality assets in research portfolios often lose momentum. Atlas identified a promising, first-in-class therapeutic for chronic migraine in Eli Lilly’s pipeline and negotiated an externalization and buy-back option, creating Arteaus Therapeutics to develop the asset through ...Estimated Reading Time: 1 min
Arsia Therapeutics - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/arsia-therapeutics
- Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date 2013. Founders Alan Crane, Alexander Klibanov, Robert Langer. Operating Status Active. Last Funding Type Seed. Company Type For Profit. Contact Email [email protected]. Phone Number (617)863-3693. Arsia Therapeutics’ mission is to improve access to these life ...
The Arteaus Therapeutics Story: R&D Externalization with ...
- https://lifescivc.com/2014/01/the-arteaus-therapeutics-story-win-win-rd-externalization-with-eli-lilly/
- Jan 13, 2014 · Arteaus has been one of the latter, and was the first of our Atlas Venture Development Corp initiatives, which began in the first half of 2010. Although it has morphed into more concept than formal corporation, the essence of this type of deal is simple: enable R&D externalization so that Pharma companies can access project financing, open ...
The Arteaus Therapeutics Story: R&D Externalization ...
- https://www.forbes.com/sites/brucebooth/2014/01/13/the-arteaus-therapeutics-story-rd-externalization-with-eli-lilly/
- Jan 13, 2014 · Arteaus was an early element of their evolving effort around creative R&D externalization models, now called their “Capital Funds Portfolio”, and is the first winner in that group. It's a ...
Have you found Arteaus Therapeutics Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.